Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy
Autor: | Rier, Hánah N., Jager, Agnes, Sleijfer, Stefan, van Rosmalen, Joost, Kock, Marc C.J.M., Levin, Mark-David |
---|---|
Zdroj: | In The Breast February 2017 31:9-15 |
Databáze: | ScienceDirect |
Externí odkaz: |